Replies to post #181147 on Biotech Values

[jq1234]

Now both title and body are updated, it is quite clear the front line trial is for accelerated phase only:

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

http://clinicaltrials.gov/ct2/show/NCT01570868?term=ponatinib&rank=3

As I had argued here while you insisted otherwise: http://investorshub.advfn.com/boards/replies.aspx?msg=105199692